| mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |